pharma · Major Depression Disorder · Major Depression Disorders
Mylan Specialty
Mylan Pharma UK
Mylan Specialty clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- napa, USA
- Employees
- 233
- Programs
- 4
- Drugs
- 10
- Patents
- 0
Mylan Specialty projects
4 ClinicalTrials.gov programs sponsored by Mylan Specialty.
Mylan Specialty has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
MYL-1603N-3001
Mylan Pharma UK
Major Depression Disorder
1 trial -
MYL-1603N-3002
Mylan Pharma UK
Major Depression Disorders
1 trial -
MR-130A-01
Mylan Pharma UK
Investigation of maintenance of ovulation inhibition after intentional application errors for indication of contraception in healthy subjects
1 trial -
EPIN-IJS-1002
Mylan Pharma UK
Allergic reactions (Type 1), including anaphylaxis, idiopathic anaphylaxis or exercise-induced anaphylaxis
1 trial
Frequently asked questions
How many clinical projects does Mylan Specialty have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.